These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28919038)

  • 1. Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products.
    Grossman EA; Ward CC; Spradlin JN; Bateman LA; Huffman TR; Miyamoto DK; Kleinman JI; Nomura DK
    Cell Chem Biol; 2017 Nov; 24(11):1368-1376.e4. PubMed ID: 28919038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity.
    Bateman LA; Nguyen TB; Roberts AM; Miyamoto DK; Ku WM; Huffman TR; Petri Y; Heslin MJ; Contreras CM; Skibola CF; Olzmann JA; Nomura DK
    Chem Commun (Camb); 2017 Jun; 53(53):7234-7237. PubMed ID: 28352901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target Identification of Bioactive Covalently Acting Natural Products.
    Nomura DK; Maimone TJ
    Curr Top Microbiol Immunol; 2019; 420():351-374. PubMed ID: 30105423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.
    Counihan JL; Wiggenhorn AL; Anderson KE; Nomura DK
    ACS Chem Biol; 2018 Aug; 13(8):1970-1977. PubMed ID: 30004670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
    Carratù MR; Signorile A; De Rasmo D; Reale A; Vacca A
    Curr Med Chem; 2016; 23(38):4286-4296. PubMed ID: 27758717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the anti-cancer natural product nimbolide for targeted protein degradation.
    Spradlin JN; Hu X; Ward CC; Brittain SM; Jones MD; Ou L; To M; Proudfoot A; Ornelas E; Woldegiorgis M; Olzmann JA; Bussiere DE; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Maimone TJ; Nomura DK
    Nat Chem Biol; 2019 Jul; 15(7):747-755. PubMed ID: 31209351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells.
    Berdan CA; Ho R; Lehtola HS; To M; Hu X; Huffman TR; Petri Y; Altobelli CR; Demeulenaere SG; Olzmann JA; Maimone TJ; Nomura DK
    Cell Chem Biol; 2019 Jul; 26(7):1027-1035.e22. PubMed ID: 31080076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bond with Me If You Can! Natural Product, Covalent Ligand, and Reactivity-Based Probe Compete for Cysteine in PP2A Complex.
    Johnson DS; Majmudar JD
    Cell Chem Biol; 2017 Nov; 24(11):1317-1318. PubMed ID: 29149589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target.
    Roberts AM; Miyamoto DK; Huffman TR; Bateman LA; Ives AN; Akopian D; Heslin MJ; Contreras CM; Rape M; Skibola CF; Nomura DK
    ACS Chem Biol; 2017 Apr; 12(4):899-904. PubMed ID: 28186401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional importance of PP2A regulatory subunit loss in breast cancer.
    Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM
    Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK.
    Xie F; Bao X; Yu J; Chen W; Wang L; Zhang Z; Xu Q
    Oncotarget; 2015 Sep; 6(28):25660-76. PubMed ID: 26308070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Deoxy-Δ
    Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
    Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells.
    Cai F; Zhang L; Xiao X; Duan C; Huang Q; Fan C; Li J; Liu X; Li S; Liu Y
    Oncol Rep; 2016 Aug; 36(2):1180-6. PubMed ID: 27350399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Discovery and biosynthesis of natural products with anti-cancer activities.
    Deng H
    Anticancer Agents Med Chem; 2015; 15(3):276. PubMed ID: 25801124
    [No Abstract]   [Full Text] [Related]  

  • 15. Chrysophanol selectively represses breast cancer cell growth by inducing reactive oxygen species production and endoplasmic reticulum stress via AKT and mitogen-activated protein kinase signal pathways.
    Park S; Lim W; Song G
    Toxicol Appl Pharmacol; 2018 Dec; 360():201-211. PubMed ID: 30300626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of protein phosphatase 2A facilitated an early stage of chemical carcinogenesis.
    Ishii Y; Kuroda K; Matsushita K; Yokoo Y; Takasu S; Kijima A; Nohmi T; Ogawa K; Umemura T
    Toxicol Appl Pharmacol; 2017 Dec; 336():75-83. PubMed ID: 29054680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3.
    Belcher BP; Machicao PA; Tong B; Ho E; Friedli J; So B; Bui H; Isobe Y; Maimone TJ; Nomura DK
    Chembiochem; 2023 Jul; 24(14):e202300111. PubMed ID: 36964942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
    Huang Q; Qin S; Yuan X; Zhang L; Ji J; Liu X; Ma W; Zhang Y; Liu P; Sun Z; Zhang J; Liu Y
    Oncol Rep; 2017 Jul; 38(1):598-606. PubMed ID: 28560452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable Hotspots.
    Ward CC; Kleinman JI; Nomura DK
    ACS Chem Biol; 2017 Jun; 12(6):1478-1483. PubMed ID: 28445029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimagining Druggability Using Chemoproteomic Platforms.
    Spradlin JN; Zhang E; Nomura DK
    Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.